Download PDF
CC BY-NC-ND 4.0 · J Lab Physicians 2019; 11(03): 284-286
DOI: 10.4103/JLP.JLP_57_19
Case Report

Pleural effusion due to Chryseobacterium indologenes: Case report and review of literature

Nazneen Arif
Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India
,
Swati Khullar
Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India
,
Ratnesh Kumar
Department of CTVS, All India Institute of Medical Sciences, New Delhi, India
,
Shiv Kumar Choudhary
Department of CTVS, All India Institute of Medical Sciences, New Delhi, India
,
Arti Kapil
Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India
,
Benu Dhawan
Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India
› Author Affiliations Financial support and sponsorship Nil
› Further Information
Also available at
  PDF Download Permissions and Reprints

Abstract

Chryseobacterium indologenes is found ubiquitously in the environment; it rarely causes human disease. Hence, we report a case of C. indologenes-associated pleural effusion in a patient with aortic dissection. Postoperatively, the patient developed massive right-sided pleural effusion with underlying consolidated lung. Culture of the pleural fluid yielded pure growth of C. indologenes which was susceptible to cotrimoxazole, minocycline, and tigecycline. Therapy was modified; tigecycline and cotrimoxazole were started following which the patient showed improvement, and subsequent cultures of the pleural fluid were sterile. This report promotes awareness of this organism as an emerging pathogen in lung infections and emphasizes the importance of targeted therapy.

Key words

Aortic dissection - Chryseobacterium indologenes - pleural effusion


Publication History

Received: 05 April 2019

Accepted: 16 June 2019

Article published online:
07 April 2020

© 2009.

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • References

  • 1 Cunha V, Ferreira M, Fonseca AG, Diogo J. Community-acquired Chryseobacterium indologenes in an immunocompetent patient. JMM Case Reports 2014;1:1-2.
  • 2 Nulens E, Bussels B, Bols A, Gordts B, Van Landuyt HW. Recurrent bacteremia by Chryseobacterium indologenes in an oncology patient with a totally implanted intravascular device. Clin Microbiol Infect 2001;7:391-3.
  • 3 Fraser SL, Jorgensen JH. Reappraisal of the antimicrobial susceptibilities of Chryseobacterium and Flavobacterium species and methods for reliable susceptibility testing. Antimicrob Agents Chemother 1997;41:2738-41.
  • 4 Chang JC, Hsueh PR, Wu JJ, Ho SW, Hsieh WC, Luh KT. Antimicrobial susceptibility of flavobacteria as determined by agar dilution and disk diffusion methods. Antimicrob Agents Chemother 1997;41:1301-6.
  • 5 Chang YC, Lo HH, Hsieh HY, Chang SM. Identification, epidemiological relatedness, and biofilm formation of clinical Chryseobacterium indologenes isolates from central Taiwan. J Microbiol Immunol Infect 2015;48:559-64.
  • 6 Agarwal S, Kakati B, Khanduri S. Severe sepsis due to Chryseobacterium indologenes, a possible emergent multidrug-resistant organism in intensive care unit-acquired infections. Indian J Crit Care Med 2018;22:817-9.
  • 7 Soydan S, Ignak S, Unay Demirel O, Karadaǧ G, Aykent A, Aslan S. Chryseobacterium indologenes infection in a patient with chronic obstructive pulmonary disease. Drug Discov Ther 2017;11:165-7.
  • 8 Imataki O, Uemura M. Chryseobacterium indologenes, a possible emergent organism resistant to carbapenem antimicrobials after stem cell transplantation. Clin Case Rep 2017;5:22-5.
  • 9 Chiscano-Camón L, Ruiz-Rodríguez JC, Alcaraz R, Ferrer R. Ventilator-associated pneumonia by Chryseobacterium indologenes. Med Clin (Barc) 2016;146:e61-2.
  • 10 Peñasco Y, Duerto J, González-Castro A, Domínguez MJ, Rodríguez-Borregán JC. Ventilator-associated pneumonia due to Chryseobacterium indologenes. Med Intensiva 2016;40:66-7.
  • 11 Nemli SA, Demirdal T, Ural S. A case of healthcare associated pneumonia caused by Chryseobacterium indologenes in an immunocompetent patient. Case Rep Infect Dis 2015;2015:483923.
  • 12 Ben Salah I, Fekih Hassen M, Ben Haj Khalifa A, Ben Sik Ali H, Tilouche N, Kheder M, et al. Chryseobacterium indologenes in ventilator-associated pneumonia:First reported case in Tunisia. Rev Pneumol Clin 2015;71:374-5.
  • 13 Shahul HA, Manu MK, Mohapatra AK, Chawla K. Chryseobacterium indologenes pneumonia in a patient with non-Hodgkin's lymphoma. BMJ Case Rep 2014;2014. pii: bcr2014204590.
  • 14 Monteen MR, Ponnapula S, Wood GC, Croce MA, Swanson JM, Boucher BA, et al. Treatment of Chryseobacterium indologenes ventilator-associated pneumonia in a critically ill trauma patient. Ann Pharmacother 2013;47:1736-9.
  • 15 Yasmin S, Garcia G, Sylvester T, Sunenshine R. Chryseobacterium indologenes in a woman with metastatic breast cancer in the United States of America: A case report. J Med Case Rep 2013;7:190.
  • 16 Ferreira Rde S, Brandão FF, Lobo SM. Chryseobacterium indologenes infection: A case report. Rev Bras Ter Intensiva 2010;22:96-8.
  • 17 Reynaud I, Chanteperdrix V, Broux C, Pavese P, Croizé J, Maurin M, et al. A severe form of Chryseobacterium indologenes pneumonia in an immunocompetent patient. Med Mal Infect 2007;37:762-4.
  • 18 Jain V, Sahu C, Afzal Hussain NA, Ghar M, Prasad KN. The era of device colonizers: Chryseobacterium indologenes infections from a tertiary care center in North India. Indian J Crit Care Med 2018;22:537-40.
  • 19 Hsueh PR, Teng LJ, Yang PC, Ho SW, Hsieh WC, Luh KT. Increasing incidence of nosocomial Chryseobacterium indologenes infections in Taiwan. Eur J Clin Microbiol Infect Dis 1997;16:568-74.
  • 20 González-Castro A, Alsasua A, Peñasco Y, Rodríguez JC, Duerto J. Tracheo-bronchitis and pneumonia associated with mechanical ventilation by Chryseobacterium indologenes. Rev Esp Anestesiol Reanim 2017;64:294-8.